menu
closed
more experienced
팝업레이어 알림
COMPANY OVERVIEW
ONCOZEN is an oncology-focused biotechnology company devoted to provide
innovative therapies to people bravely facing cancer and rare diseases.
We see new possibilities to responsibly develop and
commercialize First-in-class & Best-in-class treatments.
PLATFORM
TECHNOLOGY
A new modality that diversifies
degradable disease-causing proteins.
A technology that targets and degrades
disease-causing proteins using the body's
UPS (Ubiquitin Proteasome System)
mediated by Chaperone complexes.
Head Office
- Address3rd Floor, A-05, 194-25, Osongsaengmyeong 1-ro, Osong-eup, Cheongju-si, Chungcheongbuk-do, South Korea (Cheongju SB Plaza)
- E-MailOZ2020@oncozen.co.kr
R&D Center 1
- AddressC-713,724, Munjeong Hyundai Knowledge Industry Center, 7, Beobwon-ro 11-gil, Songpa-gu,Seoul
- E-MailOZ2020@oncozen.co.kr
R&D Center 2
- Address#302, College of Pharmacy, Jeonbuk National University, 20 Geonji-ro, Deokjin-gu, Jeonju-si, Jeollabuk-do, South Korea
- E-MailOZ2020@oncozen.co.kr